Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 13 of 13

Download this page as JSON

List	Outcome	Time frame	Description
Primary	Treatment Patterns - Safety	2 Years	Incidence and severity of Treatment-emergent serious AEs (SAEs) and AEs (TEAs)
Primary	Treatment Patterns - Effectiveness (a)	2 Years	Objective response rate (ORR)
Primary	Treatment Patterns - Effectiveness (b)	2 Years	Complete response (CR) rate
Primary	Treatment Patterns - Effectiveness (c)	2 Years	Duration of response (DoR)
Primary	Treatment Patterns - Effectiveness (d)	2 Years	OS
Primary	Treatment Patterns - Effectiveness (e)	2 Years	Progression-free survival (PFS)
Primary	Treatment Patterns - Effectiveness (f)	2 Years	Event-free survival (EFS)
Secondary	Physician-reported clinical outcome (a)	2 Years	Number of treatment lines prior to receiving tafasitamab
Secondary	Physician-reported clinical outcome (b)	2 Years	Distribution of treatment regimens by lines of therapy prior to and subsequent to tafasitamab treatment Duration of tafasitamab treatment (regardless of concomitant treatment with lenalidomide)
Secondary	Physician-reported clinical outcome (c)	2 Years	Duration of combination treatment (i.e., duration of treatment with both tafasitamab and lenalidomide)
Secondary	Physician-reported clinical outcome (d)	2 Years	Modifications of dose and treatment schedule of tafasitamab and/or lenalidomide
Secondary	Physician-reported clinical outcome (e)	2 Years	Incidence of tafasitamab use with combination partners other than lenalidomide
Secondary	Physician-reported clinical outcome (f)	2 Years	Incidence of tafasitamab use as monotherapy (i.e., without any combination partners)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04981795/registered

API reference For AI assistants